207 related articles for article (PubMed ID: 23861369)
1. A novel experimental strategy to assess the metabolic effects of selective activation of a G(q)-coupled receptor in hepatocytes in vivo.
Li JH; Jain S; McMillin SM; Cui Y; Gautam D; Sakamoto W; Lu H; Jou W; McGuinness OP; Gavrilova O; Wess J
Endocrinology; 2013 Oct; 154(10):3539-51. PubMed ID: 23861369
[TBL] [Abstract][Full Text] [Related]
2. Regulation of hepatic glucose production by Gq-coupled receptors: potential new targets for treatment of type 2 diabetes.
Mitchell J
Endocrinology; 2013 Oct; 154(10):3495-7. PubMed ID: 24058155
[No Abstract] [Full Text] [Related]
3. Chronic activation of a designer G(q)-coupled receptor improves β cell function.
Jain S; Ruiz de Azua I; Lu H; White MF; Guettier JM; Wess J
J Clin Invest; 2013 Apr; 123(4):1750-62. PubMed ID: 23478411
[TBL] [Abstract][Full Text] [Related]
4. Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor.
Nakajima K; Wess J
Mol Pharmacol; 2012 Oct; 82(4):575-82. PubMed ID: 22821234
[TBL] [Abstract][Full Text] [Related]
5. A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.
Hu J; Stern M; Gimenez LE; Wanka L; Zhu L; Rossi M; Meister J; Inoue A; Beck-Sickinger AG; Gurevich VV; Wess J
J Biol Chem; 2016 Apr; 291(15):7809-20. PubMed ID: 26851281
[TBL] [Abstract][Full Text] [Related]
6. Skeletal Muscle-Specific Activation of G
Bone DBJ; Meister J; Knudsen JR; Dattaroy D; Cohen A; Lee R; Lu H; Metzger D; Jensen TE; Wess J
Diabetes; 2019 Jun; 68(6):1341-1352. PubMed ID: 30936140
[TBL] [Abstract][Full Text] [Related]
7. Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells.
Nakajima K; Jain S; Ruiz de Azua I; McMillin SM; Rossi M; Wess J
Mol Endocrinol; 2013 Aug; 27(8):1208-16. PubMed ID: 23820900
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of β-cell M
Zhu L; Rossi M; Cohen A; Pham J; Zheng H; Dattaroy D; Mukaibo T; Melvin JE; Langel JL; Hattar S; Matschinsky FM; Appella DH; Doliba NM; Wess J
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18684-18690. PubMed ID: 31451647
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes.
Han C; Bowen WC; Michalopoulos GK; Wu T
J Cell Physiol; 2008 Aug; 216(2):486-97. PubMed ID: 18314882
[TBL] [Abstract][Full Text] [Related]
10. Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers.
Qin K; Dong C; Wu G; Lambert NA
Nat Chem Biol; 2011 Aug; 7(10):740-7. PubMed ID: 21873996
[TBL] [Abstract][Full Text] [Related]
11. DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway.
Zhou TT; Ma F; Shi XF; Xu X; Du T; Guo XD; Wang GH; Yu L; Rukachaisirikul V; Hu LH; Chen J; Shen X
J Mol Endocrinol; 2017 Aug; 59(2):151-169. PubMed ID: 28637808
[TBL] [Abstract][Full Text] [Related]
12. A chemical-genetic approach to study G protein regulation of beta cell function in vivo.
Guettier JM; Gautam D; Scarselli M; Ruiz de Azua I; Li JH; Rosemond E; Ma X; Gonzalez FJ; Armbruster BN; Lu H; Roth BL; Wess J
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19197-202. PubMed ID: 19858481
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into M3 muscarinic acetylcholine receptor physiology and structure.
Kruse AC; Li J; Hu J; Kobilka BK; Wess J
J Mol Neurosci; 2014 Jul; 53(3):316-23. PubMed ID: 24068573
[TBL] [Abstract][Full Text] [Related]
15. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
16. Regulation of immediate-early gene transcription following activation of Gα(q)-coupled designer receptors.
Kaufmann A; Keim A; Thiel G
J Cell Biochem; 2013 Mar; 114(3):681-96. PubMed ID: 23059951
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha(q) and Galpha(i) signals.
Blaukat A; Barac A; Cross MJ; Offermanns S; Dikic I
Mol Cell Biol; 2000 Sep; 20(18):6837-48. PubMed ID: 10958680
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes-Potential Applications for Diabetes and NAFLD.
Kimura T; Pydi SP; Pham J; Tanaka N
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33076386
[TBL] [Abstract][Full Text] [Related]
19. Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice.
Zhou TT; Zhao T; Ma F; Zhang YN; Jiang J; Ruan Y; Yan QY; Wang GH; Ren J; Guan XW; Guo J; Zhao YH; Ye JM; Hu LH; Chen J; Shen X
Acta Pharmacol Sin; 2019 Sep; 40(9):1193-1204. PubMed ID: 30833709
[TBL] [Abstract][Full Text] [Related]
20. Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice.
Li JH; Gautam D; Han SJ; Guettier JM; Cui Y; Lu H; Deng C; O'Hare J; Jou W; Gavrilova O; Buettner C; Wess J
Diabetes; 2009 Dec; 58(12):2776-87. PubMed ID: 19752163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
